High serum levels of IL-6 correlate with poorer outcomes in breast cancer patients.14 The aim of this study was to compare the serum level of TPA, and IL-6 in women with breast cancer at various stages of the disease and to consider the usefulness of these tumor markers in evaluating the response to chemotherapy for these patients. Here, IL6 is linked to neoplasm.